CIK 0001660334 · Non-accelerated filer<br>Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463137900
- Phone
- 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- Open-market buys, last 90 days
- $109,690
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$109,690. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-18 | Rosenberg Noah L. CMO | Purchase | +2,030 | $4.92 | $10K | 8,587 |
| 2026-08-18 | Kirby John J. Interim CFO | Purchase | +5,000 | $4.93 | $25K | 23,962 |
| 2026-08-17 | Zawitz David Chief Operating Officer | Purchase | +6,000 | $4.98 | $30K | 27,000 |
| 2026-08-17 | Rieger Jayson CEO and President | Purchase | +5,000 | $4.91 | $25K | 207,593 |
| 2026-08-17 | Rosenberg Noah L. CMO | Purchase | +4,200 | $4.91 | $21K | 6,557 |
| 2026-08-14 | Rieger Jayson CEO and President | Purchase | +20,000 | $5.06 | $101K | 202,593 |
| 2026-06-05 | Zawitz David Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +171,340 | 171,340 | ||
| 2026-06-05 | Rieger Jayson CEO and President | Grant or award · Employee Stock Option (right to buy) | +512,269 | 512,269 | ||
| 2026-06-05 | Eichenfield Lawrence Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2026-06-05 | Nguyen Diem Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2026-06-05 | Corcoran Gavin Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2026-06-05 | Rosenberg Noah L. CMO | Grant or award · Employee Stock Option (right to buy) | +233,840 | 233,840 | ||
| 2026-06-05 | PRYGOCKI MARK A SR Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2025-12-23 | Kirby John J. Interim CFO | Grant or award | +10,000 | 18,962 | ||
| 2025-11-25 | Zawitz David Chief Operating Officer | Purchase | +10,000 | $4.24 | $42K | 21,000 |
| 2025-11-25 | Zawitz David Chief Operating Officer | Purchase · Series C Warrant (right to buy) | +2,500 | 2,500 | ||
| 2025-11-25 | Rieger Jayson CEO and President | Purchase | +94,311 | $4.24 | $400K | 182,593 |
| 2025-11-25 | Rieger Jayson CEO and President | Purchase · Series C Warrant (right to buy) | +23,577 | 23,577 | ||
| 2025-11-25 | Rosenberg Noah L. CMO | Purchase | +2,357 | $4.24 | $10K | 2,357 |
| 2025-11-25 | Rosenberg Noah L. CMO | Purchase · Series C Warrant (right to buy) | +589 | 589 |
Page 1 of 8 · 154 trades